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In South Korea, WU polyomavirus (WUPyV) was detect-
ed in 34 (7%) of 486 children with acute lower respiratory tract 
infections, 3 (4.2%) of 72 asymptomatic children, and as coin-
fection with other respiratory viruses in 23 (67.6%) children. 
Although WUPyV was frequently detected, its clinical role has 
not been distinguished from that of coinfecting viruses. 
T
he polyomaviruses JC virus and BK virus usually pro-
duce asymptomatic infections, but in immunocom-
promised patients, they can become oncogenic or induce 
disease (1–3). In 2007, new polyoma viruses such as WU 
polyomavirus (WUPyV) and KI polyomavirus (KIPyV) 
were identiﬁ  ed in respiratory specimens from children with 
acute respiratory tract infections (4,5). Gaynor et al. (4) re-
ported WUPyV prevalence of 3.0% in Australia and 0.6% 
in the United States. Allander et al. (5) reported 1.0% prev-
alence of KIPyV in nasopharyngeal aspirates from children 
with mainly respiratory tract diseases. However, the clini-
cal roles of WUPyV and KIPyV during acute respiratory 
tract infection needed to be clariﬁ  ed because of the high 
frequency of their codetection with other respiratory virus-
es (4,5). The purpose of our study was to determine preva-
lence of recently identiﬁ  ed WUPyV and KIPyV in children 
who were asymptomatic and children who had acute lower 
respiratory tract infection.
The Study
At Sanggyepaik Hospital, Seoul, South Korea, from 
September 2006 through June 2007, nasopharyngeal as-
pirates were collected from 558 children <6 years of age: 
486 were hospitalized with acute lower respiratory tract in-
fection, and 72 were asymptomatic (those who visited the 
well-being clinic or were being admitted for elective sur-
gery). Informed consent was obtained from the children’s 
parents, and the study was approved by the internal review 
board of Sanggyepaik Hospital.
Viral RNA was extracted from each sample by using 
a QIAamp Viral RNA Mini Kit (QIAGEN GmbH, Hilden, 
Germany), and reverse transcription of 0.5 μg of each RNA 
sample was performed. All nasopharyngeal aspirates from 
the study population were tested for common respiratory 
viruses such as human respiratory syncytial virus (hRSV), 
inﬂ  uenza virus A and B, parainﬂ  uenza virus (PIV), and 
adenovirus by using multiplex reverse transcription–PCR 
(RT-PCR) (6,7). The rest of each specimen was then fro-
zen at –80oC until tested. RT-PCR assays were performed 
for rhinovirus (RV), human metapneumovirus (hMPV), 
human coronavirus (hCoV)–NL63, hCoV-OC43, hCoV-
229E, and hCoV HKU-1, as described (8–13). Positive and 
negative controls were included in each experiment.
DNA was extracted from the aspirates by using a 
QIAamp DNA Blood Mini Kit (QIAGEN GmbH). PCR 
assays were performed to detect human bocavirus (hBoV) 
by using primers for the nonstructural-1 and nucleopro-
tein-1 genes, as described (14). To detect WUPyV, PCR 
was performed by using primers AG0044 (5′-TGT TAC 
AAA TAG CTG CAG GTC AA-3′) and AG0045 (5′-
GCT GCA TAA TGG GGA GTA CC-3′); conﬁ  rmation 
was performed by using primers AG0048 (5′-TGT TTT 
TCA AGT ATG TTG CAT CC-3′) and AG0049 (5′-CAC 
CCA AAA GAC ACT TAA AAG AAA-3′), as described 
(4). KIPyV was detected by nested PCR assays that used 
primers POLVP1-39F, POLVP1-363R, POLVP1-118F, 
and POLVP1-324R, as described (5). The plasmids con-
taining major capsid protein (VP)–1 region of KIPyV and 
VP-2 region of WUPyV as positive control were donated 
by Tobias Allander and David Wang. All PCR products 
for WUPyV and KIPyV were sequenced to conﬁ  rm the 
speciﬁ  city for each virus. PCR product was examined af-
ter electrophoresis on a 1% agarose gel. Amplicon was 
puriﬁ  ed and sequenced in both directions. Nucleotide se-
quences were aligned by using BioEdit version 7.0 (www.
mbio.ncsu.edu/bioedit/bioedit.html) and presented in a 
topology tree, prepared in MEGA 3.1 (15). Using SAS 
software version 8.02 (SAS Institute, Inc., Cary, NC, 
USA), we performed the Fisher exact test to compare the 
proportion of symptomatic WUPyV patients with those 
who were in the control groups.
Of the 486 children who were hospitalized with acute 
respiratory tract infections, median age was 9 months 
(range 1–69 months); of the 72 asymptomatic children, 
median age was 14 months (range 1–77 months). The age 
distribution of patients with respiratory tract infections was 
220 (45.3%) <12 months, 196 (40.3%) 12–23 months, and 
70 (14.4%) 24–69 months. The male:female ratios of the 
symptomatic children (1.9:1) and asymptomatic children 
(1.7:1) did not differ signiﬁ  cantly. The clinical diagnoses 
for the 486 symptomatic children were bronchiolitis for 
250 children, pneumonia for 201, and croup for 35. Most 
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children in both groups had no additional underlying medi-
cal conditions at the time of admission.
Viruses were detected in 407 (83.7%) of the 486 
symptomatic children. The most frequently detected agents 
were hRSV in 101 (20.8%), RV in 91 (18.7%), hBoV in 
51 (10.5%), PIV in 48 (9.8%), and hMPV in 34 (7.0%) 
(Table). WUPyV was found in 34 (7%) and KIPyV in 5 
(1%) children in this group. A single virus infection with 
WUPyV was conﬁ  rmed for 11 patients (2.2%) and KIPyV 
for 1 (0.2%). WUPyV was detected along with other vi-
ruses in 23 (67.6%) children.
In the asymptomatic group, KIPyV was not detected, 
but WUPyV was found in 3 (4.2%) children. Signiﬁ  cant 
difference of prevalence between symptomatic and asymp-
tomatic patients was not noted with WUPyV infection (p = 
0.6) but was found with hBoV infection (p = 0.001). Most 
of the WUPyV infections were detected in May and June 
(Figure). The clinical symptoms of WUPyV infection in 
children were similar to those of other viral respiratory 
tract infections such as hRSV and hBoV. Gastrointestinal 
symptoms were found in 23.5% (8/34) of WUPyV-positive 
children. The 31 WUPyV strains detected in symptomatic 
children and 3 WUPyV strains in asymptomatic children, 
which were directly sequenced, clustered into 1 VP2 lin-
eage (GenBank accession nos. EF639268–EF639288, 
EF655818–655825, and EU041602–041606). Our isolates 
showed 98%–100% nucleotide identity with the VP-2 re-
gion of the WUPyV reference strain (S1). Analysis of the 
KIPyV strains showed the same sequence with the VP-
1 region of the KIPyV strain (GenBank accession nos. 
EF639289, EF655826–655827, and EU041609–041610).
Conclusions 
This prospective study shows that recently identiﬁ  ed 
WUPyVs are prevalent in South Korean children with 
acute lower respiratory tract infections. Our detection of 
WUPyV in 34 (7.0%) of 486 children with acute lower re-
spiratory tract infection suggests that the virus is prevalent 
in South Korea. Our ﬁ  nding of 27 (6.5%) WUPyV-posi-
tive samples among 416 patients <24 months of age com-
pared with 7 (10%) positive samples from 70 patients >24 
months of age suggests that WUPyV infection may occur 
more frequently in older children than in younger children; 
however, studies for latent infection of the virus are needed 
to conﬁ  rm. Clinical diagnoses for patients with WUPyV-
positive results only included bronchiolitis, tracheobron-
chitis, pneumonia, and croup. Coinfection of WUPyV with 
other respiratory viruses, especially hRSV, did not seem 
to inﬂ  uence the severity of disease, although we did not 
perform statistical analysis. Although our study tested for 
more viruses than previous studies and included a control 
group, whether detection of WUPyV in nasopharyngeal 
specimens means infection or just transmission in the respi-
ratory tract remains unclear. We performed PCR assays for 
WUPyV in stool samples from 72 children who had acute 
gastroenteritis during the same study period, but it was not 
detected (data not shown). 
Our study’s limitations include small population size, 
short study period, lack of testing for bacterial pathogens, 
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Table. Detection of viruses among 486 children with acute lower 
respiratory tract infection, Seoul, South Korea* 
Virus   No. positive (%) 
Single virus infection  407 (83.7) 
  HRSV   101 (20.8) 
 RV  91  (18.7) 
 HBoV  51  (10.5) 
  PIV†    48 (9.9) 
 hMPV  34  (7.0) 
  WUPyV   34 (7.0) 
  AdV   22 (4.5) 
 HCoV‡  15  (3.0) 
  Influenza virus  6 (1.2) 
 KIPyV  5  (1.0) 
Coinfection with polyomaviruses and  
other viruses 
27 (5.5) 
  WUPyV + hRSV   6
  WuPyV + RV  5
  WUPyV + PIV  5
  WUPyV + hMPV  2
  KIPyV + PIV  2
  KIPyV + hCoV-NL63  1
  KIPyV + RV  1
  WUPyV + RV + PIV  2
  WUPyV + hBoV + PIV  1
  WUPyV + hRSV + hBoV  1
  WUPyV + hCoV-NL63 + PIV  1
*HRSV, human respiratory syncytial virus; RV, rhinovirus; hBoV, human 
bocavirus; PIV, parainfluenzavirus; hMPV, human metapneumovirus; 
WUPyV, WU polyomavirus; AdV, adenovirus; HCoV, human coronavirus; 
KIPyV, KI polyomavirus. 
†PIV type 1 in 23 patients, PIV type 2 in 7, PIV type 3 in 10, and PIV type 
4 in 8. 
‡hCoV-NL63 in 3 patients, hCoV-OC43 in 1, and hCoV-229E in 1.  
Figure. Seasonal distribution of WU polyomavirus (WUPyV) in 
children hospitalized with acute lower respiratory tract infection, 
September 2006–June 2007. Total no. WUPyV-positive samples = 
34. Number in parentheses after each month is total number of 
samples tested.DISPATCHES
and limitation to hospitalized patients. Our ﬁ  nding of KPyV 
in 5 (1.0%) of 486 children who had respiratory symptoms 
and were mostly coinfected with other respiratory viruses 
is similar to that of a previous study (5). In conclusion, 
WUPyV was frequently found in South Korean children 
with acute lower respiratory tract infections, but further 
studies are needed to distinguish the clinical role of this 
virus from that of other coinfecting respiratory viruses.
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